RECRUITING

Low-Dose Total Skin Electron Therapy in Treating Patients With Refractory or Relapsed Stage IB-IIIA Mycosis Fungoides

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This clinical trial studies low- dose total skin electron therapy in treating patients with stage IB-IIIA mycosis fungoides that has not responded to previous treatment (refractory) or has returned after a period of improvement (relapsed). Radiation therapy uses high energy electrons to kill tumor cells and shrink tumors. Rotisserie technique is a method in which the patient receives total skin electron therapy while standing on a rotating platform. Giving low dose total skin electron therapy using rotisserie technique may kill tumor cells, while having fewer side effects, and may allow therapy to be repeated in future if clinically indicated.

Official Title

Prospective Observational Trial of Low-Dose Total Skin Electron Therapy in Mycosis Fungoides Using Rotisserie Technique

Quick Facts

Study Start:2016-05-22
Study Completion:2026-09
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT02702310

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Biopsy confirmed mycosis fungoides stage IB-IIIA
  2. * Skin manifestations of mycosis fungoides that are refractory to or have relapsed on at least one prior therapy, which may include topical steroids
  3. * Life expectancy \> 6 months
  1. * Serious medical condition that would make treatment unsafe
  2. * Pregnant or lactating patient

Contacts and Locations

Study Contact

VICC Clinical Trials Information Program
CONTACT
800-811-8480

Principal Investigator

Austin Kirschner, MD, PhD
PRINCIPAL_INVESTIGATOR
Vanderbilt-Ingram Cancer Center

Study Locations (Sites)

Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, 37232
United States

Collaborators and Investigators

Sponsor: Vanderbilt-Ingram Cancer Center

  • Austin Kirschner, MD, PhD, PRINCIPAL_INVESTIGATOR, Vanderbilt-Ingram Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2016-05-22
Study Completion Date2026-09

Study Record Updates

Study Start Date2016-05-22
Study Completion Date2026-09

Terms related to this study

Additional Relevant MeSH Terms

  • Recurrent Mycosis Fungoides
  • Refractory Mycosis Fungoides
  • Stage I Mycosis Fungoides
  • Stage II Mycosis Fungoides
  • Stage III Mycosis Fungoides